JP2023521772A5 - - Google Patents

Info

Publication number
JP2023521772A5
JP2023521772A5 JP2022561487A JP2022561487A JP2023521772A5 JP 2023521772 A5 JP2023521772 A5 JP 2023521772A5 JP 2022561487 A JP2022561487 A JP 2022561487A JP 2022561487 A JP2022561487 A JP 2022561487A JP 2023521772 A5 JP2023521772 A5 JP 2023521772A5
Authority
JP
Japan
Prior art keywords
transaminase
manipulated
seq
polypeptide sequence
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022561487A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521772A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025967 external-priority patent/WO2021207200A2/en
Publication of JP2023521772A publication Critical patent/JP2023521772A/ja
Publication of JP2023521772A5 publication Critical patent/JP2023521772A5/ja
Pending legal-status Critical Current

Links

JP2022561487A 2020-04-10 2021-04-06 操作されたトランスアミナーゼポリペプチド Pending JP2023521772A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063008047P 2020-04-10 2020-04-10
US63/008,047 2020-04-10
PCT/US2021/025967 WO2021207200A2 (en) 2020-04-10 2021-04-06 Engineered transaminase polypeptides

Publications (2)

Publication Number Publication Date
JP2023521772A JP2023521772A (ja) 2023-05-25
JP2023521772A5 true JP2023521772A5 (cg-RX-API-DMAC7.html) 2024-03-13

Family

ID=78005463

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561487A Pending JP2023521772A (ja) 2020-04-10 2021-04-06 操作されたトランスアミナーゼポリペプチド

Country Status (7)

Country Link
US (3) US11788071B2 (cg-RX-API-DMAC7.html)
EP (1) EP4133064A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023521772A (cg-RX-API-DMAC7.html)
CN (1) CN115427557A (cg-RX-API-DMAC7.html)
CA (1) CA3179751A1 (cg-RX-API-DMAC7.html)
IL (1) IL296841A (cg-RX-API-DMAC7.html)
WO (1) WO2021207200A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115851649B (zh) * 2022-04-21 2024-12-03 凯莱英医药集团(天津)股份有限公司 转氨酶突变体及其应用
CN118909842B (zh) * 2024-07-23 2025-07-22 苏州诺恩斯生物科技有限公司 一种制备西他列汀化合物的微生物菌株及应用
CN119193731A (zh) * 2024-09-23 2024-12-27 苏州弗莱明生物技术有限公司 一种维纳卡兰的制备方法
CN121699899B (zh) * 2026-02-12 2026-06-02 天津科技大学 一种转氨酶突变体、方法及其在制备罗替戈汀关键手性中间体中的应用

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600692A (en) 1983-02-10 1986-07-15 Purification Engineering, Inc. Immobilized cells for preparing phenylalanine
CA1338400C (en) 1983-08-31 1996-06-18 David H. Gelfand Recombinant fungal cellulases
US4518692A (en) 1983-09-01 1985-05-21 Genetics Institute, Inc. Production of L-amino acids by transamination
US4826766A (en) 1985-09-23 1989-05-02 Genetics Institute, Inc. Production of amino acids using coupled aminotransferases
US5316943A (en) 1988-06-14 1994-05-31 Kidman Gene E Racemic conversion of using a transaminase
US5169780A (en) 1989-06-22 1992-12-08 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
US4950606A (en) 1989-06-22 1990-08-21 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
US5300437A (en) 1989-06-22 1994-04-05 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
CA2191718A1 (en) 1994-06-03 1995-12-14 Randy M. Berka Phosphonyldipeptides useful in the treatment of cardiovascular diseases
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
WO1998031816A1 (en) 1997-01-17 1998-07-23 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
EP1717322B1 (en) 1997-01-17 2012-07-18 Codexis Mayflower Holdings, LLC Evolution of whole cells and organisms by recursive sequence recombination
DE69841075D1 (de) 1997-04-23 2009-10-01 Kaneka Corp Deoxynukleinsäure welche ein Polypeptid mit stereoselektiver Transaminase Aktivität kodiert, sowie die Deoxynukleinsäure enthaltende Transformanden
US6197558B1 (en) 1997-05-19 2001-03-06 Nsc Technologies Transaminase biotransformation process
IL136574A0 (en) 1997-12-08 2001-06-14 California Inst Of Techn A method for forming a polynucleotide of desired properties
CA2326835A1 (en) 1998-04-02 1999-10-14 Tellus Genetic Resources, Inc. A method for obtaining a plant with a genetic lesion in a gene sequence
CN1314911A (zh) 1998-05-01 2001-09-26 麦克西根股份有限公司 用dna改组优化害虫抗性基因
JP2002517995A (ja) 1998-06-17 2002-06-25 マキシジェン, インコーポレイテッド 所望の特性を有するポリヌクレオチドを生成するための方法
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
EP1104459A1 (en) 1998-08-12 2001-06-06 Maxygen, Inc. Dna shuffling of monooxygenase genes for production of industrial chemicals
ATE286136T1 (de) 1998-10-06 2005-01-15 Mark Aaron Emalfarb Transformationsystem in filamentösen fungiziden chrysosporium-wirtszellen
AU6510799A (en) 1998-10-07 2000-04-26 Maxygen, Inc. Dna shuffling to produce nucleic acids for mycotoxin detoxification
EP1129184A1 (en) 1998-11-10 2001-09-05 Maxygen, Inc. Modified adp-glucose pyrophosphorylase for improvement and optimation of plant phenotypes
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
JP2002534965A (ja) 1999-01-19 2002-10-22 マキシジェン, インコーポレイテッド 所望の特徴を有する文字ストリング、ポリヌクレオチドおよびポリペプチドを作製するための方法
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
IL144657A0 (en) 1999-02-11 2002-06-30 Maxygen Inc High throughput mass spectrometry
AU3391900A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Encryption of traits using split gene sequences
US6703240B1 (en) 1999-04-13 2004-03-09 Maxygar, Inc. Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
US6686515B1 (en) 1999-11-23 2004-02-03 Maxygen, Inc. Homologous recombination in plants
SG121902A1 (en) 2000-01-11 2006-05-26 Maxygen Inc Integrated systems for diversity generation and screening
AU4964101A (en) 2000-03-30 2001-10-15 Maxygen Inc In silico cross-over site selection
AU2001249811B2 (en) 2000-04-03 2006-06-08 Maxygen, Inc. Subtilisin variants
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
EP2315145B1 (en) 2002-03-01 2015-11-25 Codexis Mayflower Holdings, LLC Methods, systems, and software for identifying functional biomolecules
WO2003078583A2 (en) 2002-03-09 2003-09-25 Maxygen, Inc. Optimization of crossover points for directed evolution
US20050009151A1 (en) 2003-07-10 2005-01-13 Pharmacia Corporation Methods for the stereospecific and enantiomeric enrichment of beta-amino acids
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
US8962298B2 (en) 2006-05-02 2015-02-24 Butamax Advanced Biofuels Llc Recombinant host cell comprising a diol dehydratase
EP2118281A2 (en) 2007-02-12 2009-11-18 Codexis, Inc. Structure-activity relationships
WO2008127646A2 (en) 2007-04-11 2008-10-23 Dsm Ip Assets B.V. Transaminase-based processes for preparation of pregabalin
US8504498B2 (en) 2008-02-12 2013-08-06 Codexis, Inc. Method of generating an optimized, diverse population of variants
WO2009102901A1 (en) 2008-02-12 2009-08-20 Codexis, Inc. Method of generating an optimized, diverse population of variants
ES2705694T3 (es) 2008-06-13 2019-03-26 Codexis Inc Método de síntesis de variantes de polinucleótidos
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
HUE036104T2 (hu) * 2009-01-08 2018-06-28 Codexis Inc Transzamináz polipeptidek
JP5707344B2 (ja) 2009-02-26 2015-04-30 コデクシス, インコーポレイテッド トランスアミナーゼ生体触媒
CN102597226B (zh) 2009-06-22 2015-08-19 科德克希思公司 转氨酶反应
CA2769795C (en) 2009-08-05 2020-01-07 Infinity Pharmaceuticals, Inc. Enzymatic transamination of cyclopamine analogs
WO2013003290A1 (en) 2011-06-28 2013-01-03 Codexis, Inc. Protein variant generation by region shuffling
DK2582799T3 (en) 2010-06-17 2018-02-12 Codexis Inc BIOCATALATORS AND PROCEDURES FOR THE SYNTHESIS OF (S) -3- (1-AMINOETHYL) -PHENOL
US8932836B2 (en) 2010-08-16 2015-01-13 Codexis, Inc. Biocatalysts and methods for the synthesis of (1R,2R)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine
CN103608355B (zh) 2011-06-24 2016-06-29 默沙东公司 固定化转氨酶和生产及使用固定化转氨酶的方法
EP3578557B1 (en) 2012-03-23 2023-09-20 Novartis AG Chemical process for preparing spiroindolones and intermediates thereof
WO2013142770A1 (en) * 2012-03-23 2013-09-26 Codexis, Inc. Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
US20150133698A1 (en) 2012-04-20 2015-05-14 Codexis, Inc. Production of fatty alcohols from engineered microorganisms
SG11201504752YA (en) 2012-12-21 2015-07-30 Codexis Inc Engineered biocatalysts and methods for synthesizing chiral amines
US9617573B2 (en) * 2013-02-28 2017-04-11 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
WO2018231462A1 (en) * 2017-06-14 2018-12-20 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
US20200291366A1 (en) * 2017-09-12 2020-09-17 Igc Bio, Inc. Pross optimized enzymes
EP4234555A3 (en) 2019-04-11 2024-01-03 Bristol-Myers Squibb Company Novel synthetic options towards the manufacture of (6r,10s)-10- {4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)- pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15 -(metheno)pyrazolo [4,3-b] [1,7] diazacyclotetradecin-5(6h)-one

Similar Documents

Publication Publication Date Title
JP2022062113A5 (cg-RX-API-DMAC7.html)
JP2023516226A5 (cg-RX-API-DMAC7.html)
NZ592082A (en) Promoters for recombinant viral expression
JP2019517799A5 (cg-RX-API-DMAC7.html)
JP2009540801A5 (cg-RX-API-DMAC7.html)
JP2023544408A5 (cg-RX-API-DMAC7.html)
JP2024028452A5 (cg-RX-API-DMAC7.html)
EA201991443A1 (ru) ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9
JP2007502114A5 (cg-RX-API-DMAC7.html)
JP2005052158A5 (cg-RX-API-DMAC7.html)
Payne et al. Isolation of the genomic clone for pathogenesis-related protein 1a from Nicotiana tabacum cv. Xanthi-nc
JP2019519243A5 (cg-RX-API-DMAC7.html)
JP2025509233A5 (cg-RX-API-DMAC7.html)
JP2024009801A5 (cg-RX-API-DMAC7.html)
JP2025163285A (ja) 熱安定性が改善したポリエチレンテレフタレート(pet)分解酵素
JP2025509737A5 (cg-RX-API-DMAC7.html)
JP2014193147A5 (cg-RX-API-DMAC7.html)
JP2024505807A (ja) 遺伝子bbd29 14900を改造した組換え菌株及びその構築方法と応用
JP2023521972A5 (cg-RX-API-DMAC7.html)
JP2023512683A5 (cg-RX-API-DMAC7.html)
CN107488221A (zh) 真菌来源的膨胀素蛋白及其基因和应用
JP2023544783A5 (cg-RX-API-DMAC7.html)
JP2022549852A5 (cg-RX-API-DMAC7.html)
JP2024526356A5 (cg-RX-API-DMAC7.html)
JPWO2019189724A5 (cg-RX-API-DMAC7.html)